Ochi H - Search Results

1

Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy.

Yoshimi S, Imamura M, Murakami E, Hiraga N, Tsuge M, Kawakami Y, Aikata H, Abe H, Hayes CN, Sasaki T, Ochi H, Chayama K. Yoshimi S, et al. Among authors: ochi h. J Med Virol. 2015 Nov;87(11):1913-20. doi: 10.1002/jmv.24255. Epub 2015 Jun 16. J Med Virol. 2015. PMID: 25954851 Clinical Trial.

2

Successful treatment of an entecavir-resistant hepatitis B virus variant.

Yatsuji H, Hiraga N, Mori N, Hatakeyama T, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Suzuki F, Kumada H, Chayama K. Yatsuji H, et al. Among authors: ochi h. J Med Virol. 2007 Dec;79(12):1811-7. doi: 10.1002/jmv.20981. J Med Virol. 2007. PMID: 17935165

3

Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice.

Kimura T, Imamura M, Hiraga N, Hatakeyama T, Miki D, Noguchi C, Mori N, Tsuge M, Takahashi S, Fujimoto Y, Iwao E, Ochi H, Abe H, Maekawa T, Arataki K, Tateno C, Yoshizato K, Wakita T, Okamoto T, Matsuura Y, Chayama K. Kimura T, et al. Among authors: ochi h. J Gen Virol. 2008 Sep;89(Pt 9):2108-2113. doi: 10.1099/vir.0.83658-0. J Gen Virol. 2008. PMID: 18753219

4

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

Abe H, Ochi H, Maekawa T, Hayes CN, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Ohishi W, Arihiro K, Kubo M, Nakamura Y, Chayama K. Abe H, et al. Among authors: ochi h. J Hepatol. 2010 Sep;53(3):439-43. doi: 10.1016/j.jhep.2010.03.022. Epub 2010 May 31. J Hepatol. 2010. PMID: 20576307

5

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.

Kawaoka T, Hayes CN, Ohishi W, Ochi H, Maekawa T, Abe H, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Tsunoda T, Nakamura Y, Kumada H, Chayama K. Kawaoka T, et al. Among authors: ochi h. J Hepatol. 2011 Mar;54(3):408-14. doi: 10.1016/j.jhep.2010.07.032. Epub 2010 Sep 19. J Hepatol. 2011. PMID: 21112660

6

Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.

Ohara E, Hiraga N, Imamura M, Iwao E, Kamiya N, Yamada I, Kono T, Onishi M, Hirata D, Mitsui F, Kawaoka T, Tsuge M, Takahashi S, Abe H, Hayes CN, Ochi H, Tateno C, Yoshizato K, Tanaka S, Chayama K. Ohara E, et al. Among authors: ochi h. J Hepatol. 2011 May;54(5):872-8. doi: 10.1016/j.jhep.2010.08.033. Epub 2010 Oct 26. J Hepatol. 2011. PMID: 21145818

7

Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy.

Kitamura S, Tsuge M, Hatakeyama T, Abe H, Imamura M, Mori N, Saneto H, Kawaoka T, Mitsui F, Hiraga N, Takaki S, Kawakami Y, Aikata H, Takahashi S, Ohishi W, Ochi H, Hayes CN, Chayama K. Kitamura S, et al. Among authors: ochi h. Antivir Ther. 2010;15(8):1087-97. doi: 10.3851/IMP1674. Antivir Ther. 2010. PMID: 21149915

8

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, Hiraga N, Kawakami Y, Aimitsu S, Kao JH, Kubo M, Tsunoda T, Kumada H, Nakamura Y, Hayes CN, Chayama K. Ochi H, et al. J Gen Virol. 2011 May;92(Pt 5):1071-1081. doi: 10.1099/vir.0.029124-0. Epub 2011 Jan 12. J Gen Virol. 2011. PMID: 21228123

9

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Hashimoto Y, Ochi H, Abe H, Hayashida Y, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Nelson Hayes C, Ohishi W, Kubo M, Tsunoda T, Kamatani N, Nakamura Y, Chayama K. Hashimoto Y, et al. Among authors: ochi h. J Med Virol. 2011 Jun;83(6):981-8. doi: 10.1002/jmv.22028. J Med Virol. 2011. PMID: 21503910

10

Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy.

Azakami T, Hayes CN, Sezaki H, Kobayashi M, Akuta N, Suzuki F, Kumada H, Abe H, Miki D, Tsuge M, Imamura M, Kawakami Y, Takahashi S, Ochi H, Nakamura Y, Kamatani N, Chayama K. Azakami T, et al. Among authors: ochi h. J Med Virol. 2011 Jun;83(6):1048-57. doi: 10.1002/jmv.22069. J Med Virol. 2011. PMID: 21503919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,053 results

Search Page

Filters